Stock listing
NASDAQ:STOK Stoke Therapeutics, Inc. Stock
Home listing (NASDAQ) of Stoke Therapeutics, Inc.
Follow Stoke Therapeutics, Inc. into a list and get an email when it puts out news.
Share price · NASDAQ:STOK
$26.61 USD +1.79 (+7.2%)
Close on Oct 20, 2026
- Day range
- $24.84 – $27.22 USDOct 20, 2026
- Volume
- 2.00M sharesOct 20, 2026
- Market cap
- $1.72B USDAt the close on Oct 20, 2026 · price × 64.53M shares outstanding
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:STOK · Home | $26.61 USD | +1.79 (+7.2%) | 1,996,804 | $24.95 | $27.22 | $24.84 | $24.82 | Close on Oct 20, 2026 |
| Frankfurt:0GT | €21.42 EUR | -0.15 (-0.7%) | — | €21.42 | €21.42 | €21.42 | €21.57 | Close on Oct 19, 2026 |
Daily closes
Last 3 months, Jul 20, 2026 – Oct 20, 2026 · NASDAQ:STOK · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $26.61 | +1.79 | +7.2% | $24.95 | $27.22 | $24.84 | 1,996,804 | |
| $24.82 | +0.65 | +2.7% | $24.49 | $25.02 | $24.13 | 694,712 | |
| $24.17 | -0.44 | -1.8% | $24.56 | $24.59 | $23.64 | 880,121 | |
| $24.61 | +1.35 | +5.8% | $23.54 | $24.62 | $23.45 | 691,898 | |
| $23.26 | +0.76 | +3.4% | $22.43 | $23.36 | $22.05 | 1,007,495 | |
| $22.50 | -1.65 | -6.8% | $24.05 | $24.06 | $22.30 | 617,938 | |
| $24.15 | -0.59 | -2.4% | $24.65 | $24.67 | $24.10 | 372,992 | |
| $24.74 | +0.79 | +3.3% | $23.98 | $25.20 | $23.79 | 918,955 | |
| $23.95 | -0.34 | -1.4% | $24.04 | $24.29 | $23.65 | 692,277 | |
| $24.29 | -0.08 | -0.3% | $24.13 | $24.70 | $23.95 | 637,100 | |
| $24.37 | -0.95 | -3.8% | $25.58 | $25.73 | $23.00 | 1,167,300 | |
| $25.32 | -0.30 | -1.2% | $25.82 | $26.31 | $24.84 | 928,400 | |
| $25.62 | -0.39 | -1.5% | $26.46 | $26.46 | $25.45 | 848,600 | |
| $26.01 | +0.01 | 0.0% | $26.06 | $26.51 | $25.91 | 1,161,200 | |
| $26.00 | +0.12 | +0.5% | $26.12 | $26.69 | $25.88 | 1,874,800 | |
| $25.88 | +0.38 | +1.5% | $25.31 | $25.99 | $25.12 | 1,076,500 | |
| $25.50 | +0.70 | +2.8% | $24.51 | $25.71 | $24.21 | 1,660,300 | |
| $24.80 | -0.49 | -1.9% | $25.47 | $25.52 | $24.80 | 1,218,100 | |
| $25.29 | -0.82 | -3.1% | $26.09 | $26.30 | $25.00 | 1,220,300 | |
| $26.11 | -3.09 | -10.6% | $29.22 | $29.22 | $26.02 | 1,201,700 | |
| $29.20 | +1.15 | +4.1% | $28.44 | $29.40 | $28.24 | 527,200 | |
| $28.05 | -0.38 | -1.3% | $28.80 | $28.80 | $27.75 | 720,000 | |
| $28.43 | -0.50 | -1.7% | $28.85 | $28.91 | $28.01 | 1,560,300 | |
| $28.93 | +1.02 | +3.7% | $28.41 | $29.13 | $28.36 | 960,100 | |
| $27.91 | -0.24 | -0.9% | $28.25 | $28.60 | $27.66 | 592,000 | |
| $28.15 | -1.45 | -4.9% | $29.56 | $29.56 | $27.82 | 1,089,900 | |
| $29.60 | +0.57 | +2.0% | $29.38 | $29.70 | $29.01 | 500,400 | |
| $29.03 | -0.31 | -1.1% | $29.82 | $30.16 | $29.01 | 587,500 | |
| $29.34 | -0.58 | -1.9% | $29.62 | $29.79 | $28.96 | 421,300 | |
| $29.92 | -0.13 | -0.4% | $29.53 | $30.53 | $29.53 | 666,300 | |
| $30.05 | +0.24 | +0.8% | $29.13 | $30.68 | $28.89 | 681,000 | |
| $29.81 | -0.18 | -0.6% | $29.41 | $30.03 | $29.15 | 714,000 | |
| $29.99 | -0.51 | -1.7% | $30.70 | $30.70 | $29.69 | 510,600 | |
| $30.50 | -0.39 | -1.3% | $31.46 | $32.12 | $29.98 | 630,800 | |
| $30.89 | -0.31 | -1.0% | $29.94 | $31.38 | $29.94 | 727,500 | |
| $31.20 | -0.42 | -1.3% | $31.37 | $32.18 | $30.58 | 1,116,100 | |
| $31.62 | -0.97 | -3.0% | $32.20 | $32.55 | $31.49 | 754,100 | |
| $32.59 | -0.50 | -1.5% | $33.01 | $33.18 | $32.00 | 939,300 | |
| $33.09 | -0.37 | -1.1% | $33.21 | $33.55 | $32.57 | 1,155,300 | |
| $33.46 | +1.14 | +3.5% | $32.70 | $33.94 | $32.45 | 728,630 | |
| $32.32 | +0.03 | +0.1% | $32.29 | $32.76 | $31.16 | 562,290 | |
| $32.29 | +0.89 | +2.8% | $31.76 | $32.77 | $31.52 | 1,274,400 | |
| $31.40 | -1.63 | -4.9% | $32.48 | $32.59 | $29.86 | 1,485,500 | |
| $33.03 | +0.89 | +2.8% | $32.75 | $33.43 | $32.52 | 1,472,200 | |
| $32.14 | +0.01 | 0.0% | $31.85 | $32.67 | $31.40 | 574,600 | |
| $32.13 | +0.86 | +2.8% | $31.09 | $32.52 | $31.09 | 444,700 | |
| $31.27 | -0.04 | -0.1% | $31.70 | $31.70 | $30.20 | 495,100 | |
| $31.31 | -1.66 | -5.0% | $33.28 | $33.28 | $31.15 | 481,000 | |
| $32.97 | +0.01 | 0.0% | $32.94 | $33.56 | $32.05 | 978,000 | |
| $32.96 | +0.73 | +2.3% | $32.18 | $33.04 | $31.23 | 1,308,700 | |
| $32.23 | -0.48 | -1.5% | $32.41 | $32.83 | $32.00 | 424,600 | |
| $32.71 | +0.78 | +2.4% | $32.00 | $32.85 | $31.62 | 866,600 | |
| $31.93 | 0.00 | 0.0% | $31.99 | $33.09 | $31.60 | 690,900 | |
| $31.93 | +0.26 | +0.8% | $32.03 | $32.85 | $31.33 | 634,800 | |
| $31.67 | +2.11 | +7.1% | $28.78 | $32.99 | $28.78 | 1,319,900 | |
| $29.56 | +0.70 | +2.4% | $28.62 | $29.65 | $28.19 | 3,152,000 | |
| $28.86 | -1.18 | -3.9% | $29.75 | $30.00 | $28.70 | 715,800 | |
| $30.04 | +0.56 | +1.9% | $29.25 | $30.09 | $28.92 | 689,500 | |
| $29.48 | +0.09 | +0.3% | $29.43 | $30.11 | $28.83 | 700,200 | |
| $29.39 | +0.08 | +0.3% | $29.67 | $29.88 | $28.49 | 598,400 | |
| $29.31 | +0.01 | 0.0% | $29.58 | $30.92 | $29.23 | 594,600 | |
| $29.30 | -0.35 | -1.2% | $29.91 | $30.30 | $28.96 | 441,800 | |
| $29.65 | +0.69 | +2.4% | $28.45 | $29.79 | $28.33 | 669,300 | |
| $28.96 | +0.15 | +0.5% | $28.57 | $29.23 | $27.96 | 416,600 | |
| $28.81 | +1.13 | +4.1% | $27.66 | $29.06 | $27.24 | 604,488 | |
| $27.68 | -1.37 | -4.7% | $29.15 | $29.42 | $27.40 | 546,520 |
- Ticker
- NASDAQ:STOK
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD
What changed lately
Latest news release · Oct 16, 2026
Stoke Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Latest earnings call · Aug 3, 2026
Stoke Therapeutics (NASDAQ:STOK) Q2 2026 Earnings Call
Replay and transcript
Latest deck · Aug 3, 2026
Q2 2026 Earnings Presentation
Earnings · 21 slides
Calls
Replays
Stoke Therapeutics (NASDAQ:STOK) Q2 2026 Earnings Call
Mon, Aug 03, 2026 · 4:30 PM ET
Watch TranscriptStoke Therapeutics (NASDAQ:STOK) Q1 2026 Earnings Call
Thu, May 07, 2026 · 4:30 PM ET
Watch TranscriptStoke Therapeutics (NASDAQ:STOK) Q3 2025 Earnings Call
Tue, Nov 04, 2025 · 4:30 PM ET
Watch Transcript
Latest news
Stoke Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Oct 16, 2026
Closed $24.82 (+2.7%) on Oct 19, 2026
Stoke Therapeutics Presents Data Supporting the Disease-Modifying Potential of STK-002 in Autosomal Dominant Optic Atrophy (ADOA) at the American Academy of Ophthalmology (AAO) 2026 Annual Meeting
Oct 12, 2026
Closed $24.15 (-2.4%) on Oct 12, 2026
Stoke Therapeutics Announces Completion of Successful Meeting with the FDA to Align on Planned U.S. NDA for Zorevunersen, an Investigational Medicine for the Treatment of Dravet Syndrome
Oct 5, 2026
Closed $25.32 (-1.2%) on Oct 5, 2026
Stoke Therapeutics Appoints Bo Cumbo to its Board of Directors, Enhancing Commercial Expertise as the Company Advances Zorevunersen Development Toward Potential FDA Approval and Commercialization
Sep 23, 2026
Closed $25.29 (-3.1%) on Sep 24, 2026
Stoke Therapeutics and Biogen Announce Presentations of Clinical Data from Studies of Zorevunersen, an Investigational Medicine for the Treatment of Dravet Syndrome, at the 16th European Epilepsy Congress (EEC)
Sep 1, 2026
Closed $30.89 (-1.0%) on Sep 1, 2026
Stoke Therapeutics to Present at the Canaccord Genuity 46th Annual Growth Conference
Aug 5, 2026
Closed $31.93 (+0.8%) on Aug 5, 2026
Stoke Therapeutics Announces Second Quarter 2026 Financial Results and Provides Business Updates
Aug 3, 2026
Closed $31.67 (+7.1%) on Aug 4, 2026
Stoke Therapeutics to Host Webcast and Conference Call to Discuss Second Quarter 2026 Business and Financial Updates
Jul 27, 2026
Closed $29.39 (+0.3%) on Jul 28, 2026
Stoke Therapeutics Appoints Thomas McCauley, Ph.D., as Chief Scientific Officer
Jul 13, 2026
Closed $29.46 (-6.1%) on Jul 13, 2026
Decks
Q2 2026 Earnings Presentation
Earnings · 21 slides · Aug 3, 2026
Q1 2026 Earnings Presentation
Earnings · 20 slides · May 7, 2026
Technical Presentation (2026)
Technical · 13 slides · 2026
Technical Presentation (2026)
Technical · 10 slides · 2026
Stoke Therapeutics, Inc. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 33 in the last 12 months · 147 in all · newest Oct 16, 2026 · oldest 2019
- Calls
- 5 calls with a replay · 5 with a transcript · latest Aug 3, 2026
- Decks
- 20 decks · latest Aug 3, 2026
Where Stoke Therapeutics, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:STOK · Home listing · This page | NASDAQ | United States | USD |
| gettex:0GT | gettex | Germany | EUR |
| Lang & Schwarz:A2PLTL | Lang & Schwarz | Germany | EUR |
| LS Exchange:A2PLTL | LS Exchange | Germany | EUR |
| BOATS:STOK | BOATS | United States | USD |
| Frankfurt:0GT | Frankfurt | Germany | EUR |
| Tradegate:0GT | Tradegate | Germany | EUR |
| Dusseldorf:0GT | Dusseldorf | Germany | EUR |
| Munich:0GT | Munich | Germany | EUR |
| Stuttgart:0GT | Stuttgart | Germany | EUR |
Log in to ask 6ix AI your own questions about Stoke Therapeutics, Inc.